Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Aligos Therapeutics Reports Positive Clinical Data for ALG-000184 and ALG-055009 at AASLD 2024 Meeting Quiver Quantitative, Inc. - Tue Nov 19, 10:56PM CST

Aligos Therapeutics reported positive clinical data on ALG-000184 for hepatitis B and ALG-055009 for liver fat reduction.Quiver AI SummaryAligos Therapeutics, Inc. announced positive results from its presentations...

ALGS : 19.49 (-1.52%)
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024 GlobeNewswire - Tue Nov 19, 12:30PM CST

ALGS : 19.49 (-1.52%)
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 3:05PM CST

ALGS : 19.49 (-1.52%)
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024 GlobeNewswire - Wed Oct 30, 3:05PM CDT

ALGS : 19.49 (-1.52%)
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184 GlobeNewswire - Tue Oct 22, 7:00AM CDT

ALGS : 19.49 (-1.52%)
Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024 GlobeNewswire - Tue Oct 15, 8:00AM CDT

ALGS : 19.49 (-1.52%)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Oct 11, 7:00AM CDT

ALGS : 19.49 (-1.52%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Higher as Investors Await Powell Speech, Debt Ceiling Optimism Lifts Sentiment Barchart - Mon May 15, 2023

June S&P 500 futures (ESM23) are up +0.39%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.32% this morning as market participants awaited an update on plans to raise the U.S. debt ceiling while...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
LNC : 35.36 (+1.55%)
PACW : 7.54 (-2.71%)
FSLR : 185.02 (+1.69%)
CS.P.DX : 34.040 (-0.58%)
NGMS : 29.45 (+0.07%)
MMP : 69.00 (+0.67%)
OKE : 117.94 (+1.02%)
ALGS : 19.49 (-1.52%)
DD : 83.23 (+0.58%)
ALB : 106.60 (-2.18%)
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2022 Financial Results Globe Newswire - Thu Aug 4, 2022

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 19.49 (-1.52%)
Aligos Therapeutics to Present at the Jefferies 2022 Healthcare Conference Globe Newswire - Mon May 23, 2022

SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 19.49 (-1.52%)

Barchart Exclusives

Disney Stock: Is DIS Still a Buy after Rallying 18% in a Month? Barchart - 36 minutes ago
Disney shares have risen considerably since the company released its fiscal Q4 2024 earnings earlier this month. The stock has room to run higher into 2025 also, given its growth prospects and reasonable valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot